Overview

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether SU011248 has activity and is safe in patients with metastatic non-small cell lung cancer (NSCLC) who have failed a platinum-containing regimen and docetaxel.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Sunitinib